Appalachia’s black lung rates highest in nearly 50 years as miners’ protections stall
Rates are now as bad as the 1970s, with thousands of miners sick and dying. Mining experts blame toxic silica…
Two people in Michigan have died after becoming ill with cyclosporiasis
They are the first reported deaths linked to a massive outbreak of the intestinal illness that began in May.
What would it take to get peptides on the shelf?
An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for…
What Cyclospora does inside the gut and how it gets there
Cyclospora, the parasite that has sickened thousands this summer in the U.S., requires time in the human digestive tract to…
FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its…
The Lumbee Tribe of N.C. wants better healthcare, but plans to fund it are in limbo
Robeson County, N.C., where most of the Lumbee Tribe's citizens live, ranks as one of the worst counties in the…
The Trump administration’s move to end subsidies for Medicare drug plans could cost consumers
Federal subsidies that have helped defray insurers' Medicare drug costs will disappear at the end of the year. Millions of…
Amid U.S. funding cuts, the International AIDS Conference faces an uncertain future
Dr. Kenneth Ngure, president-elect of the International AIDS Society, says, "We have had very good scientific advances ... yet the…
FDA panel considers easing peptide restrictions
Advisers to the Food and Drug Administration are weighing the evidence for seven different peptides. Favorable votes would pave the…
Peptides get their regulatory closeup
A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized…